188 related articles for article (PubMed ID: 22502840)
1. Substance abuse among individuals with intellectual disabilities.
Carroll Chapman SL; Wu LT
Res Dev Disabil; 2012; 33(4):1147-56. PubMed ID: 22502840
[TBL] [Abstract][Full Text] [Related]
2. Co-occurring intellectual disability and substance use disorders.
Bhatt NV; Gentile JP
AIMS Public Health; 2021; 8(3):479-484. PubMed ID: 34395697
[TBL] [Abstract][Full Text] [Related]
3. Substance use among individuals with intellectual disabilities living independently in Flanders.
Swerts C; Vandevelde S; VanDerNagel JE; Vanderplasschen W; Claes C; De Maeyer J
Res Dev Disabil; 2017 Apr; 63():107-117. PubMed ID: 27061044
[TBL] [Abstract][Full Text] [Related]
4. Substance use disorders in individuals with mild to borderline intellectual disability: current status and future directions.
van Duijvenbode N; VanDerNagel JE; Didden R; Engels RC; Buitelaar JK; Kiewik M; de Jong CA
Res Dev Disabil; 2015 Mar; 38():319-28. PubMed ID: 25577182
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment for substance-abusing people with intellectual disabilities: intervening on autonomous motivation for treatment entry.
Frielink N; Schuengel C; Kroon A; Embregts PJ
J Intellect Disabil Res; 2015 Dec; 59(12):1168-82. PubMed ID: 26369922
[TBL] [Abstract][Full Text] [Related]
6. Substance use and misuse in persons with intellectual disabilities (ID): results of a survey in ID and addiction services in Flanders.
To WT; Neirynck S; Vanderplasschen W; Vanheule S; Vandevelde S
Res Dev Disabil; 2014 Jan; 35(1):1-9. PubMed ID: 24211791
[TBL] [Abstract][Full Text] [Related]
7. Recreational substance use patterns and co-morbid psychopathology in adults with intellectual disability.
Chaplin E; Gilvarry C; Tsakanikos E
Res Dev Disabil; 2011; 32(6):2981-6. PubMed ID: 21640553
[TBL] [Abstract][Full Text] [Related]
8. [Behavioral disorders and substance abuse in adolescents with mental retardation].
Papachristou E; Anagnostopoulos D
Psychiatriki; 2014; 25(2):139-50. PubMed ID: 25035183
[TBL] [Abstract][Full Text] [Related]
9. Comparison of social circumstances, substance use and substance-related harm in soon-to-be-released prisoners with and without intellectual disability.
Bhandari A; van Dooren K; Eastgate G; Lennox N; Kinner SA
J Intellect Disabil Res; 2015 Jun; 59(6):571-9. PubMed ID: 25171498
[TBL] [Abstract][Full Text] [Related]
10. Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis.
VanDerNagel JE; Kiewik M; van Dijk M; Didden R; Korzilius HP; van der Palen J; Buitelaar JK; Uges DR; Koster RA; de Jong CA
Res Dev Disabil; 2017 Apr; 63():151-159. PubMed ID: 27133469
[TBL] [Abstract][Full Text] [Related]
11. Substance use disorders in patients with intellectual disability admitted to psychiatric hospitalisation.
Salavert J; Clarabuch A; Fernández-Gómez MJ; Barrau V; Giráldez MP; Borràs J
J Intellect Disabil Res; 2018 Nov; 62(11):923-930. PubMed ID: 29961996
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability.
van Duijvenbode N; VanDerNagel JEL
Eur Addict Res; 2019; 25(6):263-282. PubMed ID: 31330514
[TBL] [Abstract][Full Text] [Related]
13. Personality dimensions and substance use in individuals with mild to borderline intellectual disabilities.
Poelen EA; Schijven EP; Otten R; Didden R
Res Dev Disabil; 2017 Apr; 63():142-150. PubMed ID: 27765413
[TBL] [Abstract][Full Text] [Related]
14. Intellectual disability in young people in custody in New South Wales, Australia - prevalence and markers.
Haysom L; Indig D; Moore E; Gaskin C
J Intellect Disabil Res; 2014 Nov; 58(11):1004-14. PubMed ID: 24422559
[TBL] [Abstract][Full Text] [Related]
15. Determinants of multiple psychotropic drug use in patients with mild intellectual disabilities or borderline intellectual functioning and psychiatric or behavioral disorders.
Stolker JJ; Heerdink ER; Leufkens HG; Clerkx MG; Nolen WA
Gen Hosp Psychiatry; 2001; 23(6):345-9. PubMed ID: 11738466
[TBL] [Abstract][Full Text] [Related]
16. Demographic and clinical characteristics of people with intellectual disabilities with and without substance abuse disorders in a Medicaid population.
Slayter EM
Intellect Dev Disabil; 2010 Dec; 48(6):417-31. PubMed ID: 21166548
[TBL] [Abstract][Full Text] [Related]
17. Substance Use, Offending, and Participation in Alcohol and Drug Treatment Programmes: A Comparison of Prisoners with and without Intellectual Disabilities.
McGillivray JA; Gaskin CJ; Newton DC; Richardson BA
J Appl Res Intellect Disabil; 2016 May; 29(3):289-94. PubMed ID: 25754684
[TBL] [Abstract][Full Text] [Related]
18. Substance use prevention program for adolescents with intellectual disabilities on special education schools: a cluster randomised control trial.
Kiewik M; VanDerNagel JE; Kemna LE; Engels RC; DeJong CA
J Intellect Disabil Res; 2016 Mar; 60(3):191-200. PubMed ID: 26631986
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of mental health problems in adults with intellectual disabilities in Japan, associated factors and mental health service use.
Shimoyama M; Iwasa K; Sonoyama S
J Intellect Disabil Res; 2018 Nov; 62(11):931-940. PubMed ID: 29968366
[TBL] [Abstract][Full Text] [Related]
20. An exploration of substance misuse in people with intellectual disabilities.
Taggart L; McLaughlin D; Quinn B; Milligan V
J Intellect Disabil Res; 2006 Aug; 50(Pt 8):588-97. PubMed ID: 16867066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
